New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 17, 2013
10:04 EDTDHI, SXC, KFN, SXCP, USPH, TWTR, SNTS, PAA, GSK, FST, CFNOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: CareFusion (CFN) downgraded to Sell from Neutral at Goldman...Forest Oil (FST) downgraded to Neutral from Outperform at RW Baird...GlaxoSmithKline (GSK) downgraded to Hold from Buy at Deutsche Bank...Plains All American (PAA) downgraded to Hold from Buy at Deutsche Bank...Santarus (SNTS) downgraded to Hold from Buy at Stifel...Twitter (TWTR) downgraded to Neutral from Overweight at Atlantic Equities...U.S. Physical Therapy (USPH) downgraded to Market Perform at JMP Securities...SunCoke Energy Partners (SXCP) downgraded to Neutral from Outperform at Credit Suisse...KKR Financial (KFN) downgraded to Market Perform from Outperform at Wells Fargo...SunCoke Energy (SXC) downgraded to Neutral from Outperform at Credit Suisse...D.R. Horton (DHI) downgraded to Neutral from Buy at Compass Point.
News For CFN;FST;GSK;PAA;SNTS;TWTR;USPH;SXCP;KFN;SXC;DHI From The Last 14 Days
Check below for free stories on CFN;FST;GSK;PAA;SNTS;TWTR;USPH;SXCP;KFN;SXC;DHI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 15, 2014
13:18 EDTTWTRDaniel Graf to join Twitter's product team
Daniel Graf, who led efforts on Google Maps (GOOG), is joining Twitter's (TWTR) product team, Graf announced in a tweet. Reference Link
10:14 EDTGSKFDA approves Tanzeum to treat type 2 diabetes
The Food and Drug Administration approved Tanzeum subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Tanzeum has a Boxed Warning to warn that tumors of the thyroid gland have been observed in rodent studies with some GLP-1 receptor agonists, but that it is unknown whether Tanzeum causes thyroid C-cell tumors, including a type of thyroid cancer called medullary thyroid carcinoma, in humans. Tanzeum should not be used in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2. The FDA approved Tanzeum with a Risk Evaluation and Mitigation Strategy, which consists of a communication plan to inform health care providers about the serious risks associated with Tanzeum. Tanzeum is manufactured by GlaxoSmithKline.
09:13 EDTTWTRTwitter agrees to acquire social data provider Gnip
Subscribe for More Information
08:23 EDTGSKLeerink's pharma and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
08:06 EDTGSKProsonix, Mylan enter licensing deal for generic version of Flixotide, Flovent
Subscribe for More Information
06:32 EDTGSKPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
April 14, 2014
17:10 EDTTWTRTwitter's lockup expiration encompasses fully 83% shares outstanding, WSJ says
The lockup on 489M Twitter shares expires on May 5, says the Wall Street Journal. Despite the recent statement that co-founders Jack Dorsey and Evan Williams, along with CEO Richard Costolo, have no "current plans" to sell shares, the lockup expiration encompasses fully 83% of Twitter's basic shares outstanding or two-thirds of the diluted count, added the Wall Street Journal. Reference Link
16:24 EDTTWTROn The Fly: Closing Wrap
Subscribe for More Information
12:26 EDTTWTROn The Fly: Midday Wrap
Subscribe for More Information
09:23 EDTTWTRTwitter co-founders, CEO have no plans to sell shares around May 5 lockup
Subscribe for More Information
09:18 EDTTWTRTwitter co-founders, CEO state they have no plans to sell any shares
07:36 EDTTWTRTwitter exec goes to Turkey to ease tensions, Bloomberg says
Twitter's vice president of global public policy is meeting with the head of Turkey's information and Communications Technologies Authority, Tayfun Acarer, in Ankara in an effort to ease tensions in Turkey amid accusations from Prime Minister Recep Tayyip Erdoganís administration that the U.S. company evades taxes and refuses to follow Turkish law, according to Bloomberg, citing a spokesman for Acarer. Reference Link
06:40 EDTGSKGlaxoSmithKline paid bribes to Polish doctors to promote Seretide, BBC says
Subscribe for More Information
April 11, 2014
12:44 EDTTWTRHedge funds initiating shorts on Priceline, Amazon, Twitter, CNBC says
Subscribe for More Information
10:13 EDTSXCHigh option volume stocks: SXC FSL IMPV TWGP
Subscribe for More Information
10:10 EDTTWTRTwitter bounces, drops, heads for retest of session lows
Subscribe for More Information
09:37 EDTTWTRActive equity options trading on open
Subscribe for More Information
April 10, 2014
11:42 EDTGSKReport claims Tamiflu, Relenza do little to prevent the spread of flu
Subscribe for More Information
10:00 EDTTWTROn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:33 EDTTWTRTwitter upgraded to Hold from Sell at Cantor
Cantor Fitzgerald upgraded its rating on Twitter (TWTR) shares to Hold from Sell citing the recent pullback in the stock as well as the upcoming launch of new ad formats which it believes should drive monetization. Cantor maintains a $45 price target for the stock and says it continues to prefer Facebook (FB). Shares of Twitter closed yesterday up 71c to $42.49.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use